Overview
McDermott Will & Emery advised Qualium Investissement on its upcoming investment in Proengin, the French leader in the detection of chemical and biological threats. During this transaction, Qualium Investissement, a leading institutional fund in France, will become a majority shareholder in the group and will support the acceleration of Proengin’s development, along with Capital Export and current shareholders who will significantly reinvest in the transaction.
McDermott Will & Emery assisted Qualium Investissement with a team composed of:
- Grégoire Andrieux and Fabrice Piollet, partners, Claire Barra and Charline Boulenger, associates, on corporate aspects
- Antoine Vergnat, partner, Romain Desmonts and Fanny Le Pogam, associates, on tax aspects
- Pierre-Arnoux Mayoly, partner, and Hugo Lamour, associate, on financing aspects
- Sabine Naugès, partner, Charlotte Michellet and Marion Schwartz, associates, on regulatory aspects
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
